{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:49:11Z","timestamp":1790077751345,"version":"4.0.1"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:p>Ondansetron is the drug of choice to prevent nausea in women undergoing cesarean surgery and can be used to prevent neonatal abstinence syndrome (NAS). The pharmacokinetics of ondansetron have not been characterized in pregnant women or in newborns. A nonlinear mixed\u2010effects modeling approach was used to analyze plasma samples obtained from 20 nonpregnant and 40 pregnant women following a single administration of 4 or 8 mg ondansetron, from umbilical cord blood at delivery, and from neonates after birth. The analysis indicates that: ondansetron disposition is not affected by pregnancy (<jats:italic>P &gt;<\/jats:italic>0.05), but influenced by dose (<jats:italic>P &lt;<\/jats:italic>0.05), and is characterized by rapid transplacental transfer and longer elimination half\u2010life in neonates compared to their mother. A dosing regimen for prevention of NAS was designed based on the model. The regimen involves IV administration of 4 mg to the mothers shortly before cord clamping, or oral administration of 0.07 mg\/kg (or equivalently 0.04 mg\/kg IV) to neonates.<\/jats:p>","DOI":"10.1002\/cpt.5","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T16:44:03Z","timestamp":1423673043000},"page":"167-176","source":"Crossref","is-referenced-by-count":30,"title":["Ondansetron Pharmacokinetics in Pregnant Women and Neonates: Towards a New Treatment for Neonatal Abstinence Syndrome"],"prefix":"10.1111","volume":"97","author":[{"given":"MH","family":"Elkomy","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine Stanford University Stanford California USA"},{"name":"Department of Pharmaceutics and Industrial Pharmacy Beni Suef University Beni Suef Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sultan","sequence":"additional","affiliation":[{"name":"Royal Free Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine Stanford University Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Peltz","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine Stanford University Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine Stanford University Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Clavijo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology University of Colorado Anschutz Medical Campus Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Galinkin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology University of Colorado Anschutz Medical Campus Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DR","family":"Drover","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine Stanford University Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"e_1_2_9_1_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181ea7821"},{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(01)00294-X"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181a45a6b"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328322e73d"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3951"},{"key":"e_1_2_9_6_1","volume-title":"The epidemiology of unintentional drug poisoning in the United States","author":"Paulozzi L.","year":"2007"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1990.18.2.111"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.088"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03170.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600800913"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.7"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90248-1"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0730-8"},{"issue":"1","key":"e_1_2_9_14_1","first-page":"S75","article-title":"The metabolism of ondansetron","volume":"25","author":"Saynor D.A.","year":"1989","journal-title":"Eur. J. Cancer. Clin. Oncol."},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00001"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005060-00001"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645070-00004"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.021873"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2510893.x"},{"key":"e_1_2_9_20_1","first-page":"9","article-title":"Ondansetron metabolism and pharmacokinetics","volume":"19","author":"Pritchard J.F.","year":"1992","journal-title":"Semin. Oncol."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529020-00004"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018965929419"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0090-9556(25)06820-5","article-title":"Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans","volume":"23","author":"Dixon C.M.","year":"1995","journal-title":"Drug. Metab. Dispos."},{"key":"e_1_2_9_24_1","first-page":"S71","article-title":"The determination in plasma and pharmacokinetics of ondansetron","volume":"25","author":"Colthup P.V.","year":"1989","journal-title":"Eur. J. Cancer. Clin. Oncol."},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-012-0004-5"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.011"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.698261"},{"key":"e_1_2_9_28_1","volume-title":"Blood collection on filter paper for newborn screening programs; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2007"},{"key":"e_1_2_9_29_1","first-page":"655","article-title":"A rapid, sensitive and validated method for the determination of ondansetron in human plasma by reversed\u2010phase high\u2010pressure liquid chromatography","volume":"54","author":"Chandrasekar D.","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01059660"},{"key":"e_1_2_9_32_1","unstructured":"Karlsson M.O.&Holford N.H.A tutorial on visual predictive checks (Abstr 1434). <http:\/\/www.page\u2010meeting.org\/pdf_assets\/8694\u2010Karlsson_Holford_VPC_Tutorial_hires.pdf> (2008)."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_2_9_34_1","first-page":"11","article-title":"Clinical pharmacology of ondansetron in postoperative nausea and vomiting","volume":"6","author":"Baber N.","year":"1992","journal-title":"Eur. J. Anaesthesiol."},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018974501232"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.5","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T21:21:16Z","timestamp":1747603276000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1002\/cpt.5"],"URL":"https:\/\/doi.org\/10.1002\/cpt.5","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,4]]}}}